Maltodextrin imaging agents can distinguish bacterial infections from inflamed areas, according to a rat study published in JACC: Cardiovascular Imaging. Ideally, this finding could lead to novel tracers to catch infections from implanted cardiac devices (ICDs) before they require removal.